Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 11
2009 5
2010 17
2011 20
2012 17
2013 13
2014 14
2015 12
2016 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Results by year
Filters applied: . Clear all
Page 1
Drug discovery in paediatric oncology: roadblocks to progress.
Adamson PC, Houghton PJ, Perilongo G, Pritchard-Jones K. Adamson PC, et al. Nat Rev Clin Oncol. 2014 Dec;11(12):732-9. doi: 10.1038/nrclinonc.2014.149. Epub 2014 Sep 16. Nat Rev Clin Oncol. 2014. PMID: 25223555 Free PMC article. Review.
Radiation therapy may increase metastatic potential in alveolar rhabdomyosarcoma.
Woods GM, Bondra K, Chronowski C, Leasure J, Singh M, Hensley L, Cripe TP, Chakravarti A, Houghton P. Woods GM, et al. Pediatr Blood Cancer. 2015 Sep;62(9):1550-1554. doi: 10.1002/pbc.25516. Epub 2015 Mar 19. Pediatr Blood Cancer. 2015. PMID: 25790258 Free PMC article.
Statistical inference for tumor growth inhibition T/C ratio.
Wu J. Wu J. J Biopharm Stat. 2010 Sep;20(5):954-64. doi: 10.1080/10543401003618983. J Biopharm Stat. 2010. PMID: 20721784 Free PMC article.
Initial testing of JNJ-26854165 (Serdemetan) by the pediatric preclinical testing program.
Smith MA, Gorlick R, Kolb EA, Lock R, Carol H, Maris JM, Keir ST, Morton CL, Reynolds CP, Kang MH, Arts J, Bashir T, Janicot M, Kurmasheva RT, Houghton PJ. Smith MA, et al. Pediatr Blood Cancer. 2012 Aug;59(2):329-32. doi: 10.1002/pbc.23319. Epub 2011 Sep 15. Pediatr Blood Cancer. 2012. PMID: 21922647 Free PMC article.
Intrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor.
Forest A, Amatulli M, Ludwig DL, Damoci CB, Wang Y, Burns CA, Donoho GP, Zanella N, Fiebig HH, Prewett MC, Surguladze D, DeLigio JT, Houghton PJ, Smith MA, Novosiadly R. Forest A, et al. Mol Cancer Res. 2015 Dec;13(12):1615-26. doi: 10.1158/1541-7786.MCR-15-0279. Epub 2015 Aug 11. Mol Cancer Res. 2015. PMID: 26263910 Free PMC article.
Interval approach to assessing antitumor activity for tumor xenograft studies.
Wu J, Houghton PJ. Wu J, et al. Pharm Stat. 2010 Jan-Mar;9(1):46-54. doi: 10.1002/pst.369. Pharm Stat. 2010. PMID: 19306260 Free PMC article.
Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing program.
Kang MH, Reynolds CP, Maris JM, Gorlick R, Kolb EA, Lock R, Carol H, Keir ST, Wu J, Lyalin D, Kurmasheva RT, Houghton PJ, Smith MA. Kang MH, et al. Pediatr Blood Cancer. 2014 Aug;61(8):1486-9. doi: 10.1002/pbc.24989. Epub 2014 Feb 20. Pediatr Blood Cancer. 2014. PMID: 24623675 Free PMC article.
Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing program.
Carol H, Maris JM, Kang MH, Reynolds CP, Kolb EA, Gorlick R, Keir ST, Wu J, Kurmasheva RT, Houghton PJ, Smith MA, Lock RB, Lyalin D. Carol H, et al. Pediatr Blood Cancer. 2014 Aug;61(8):1493-6. doi: 10.1002/pbc.25026. Epub 2014 Mar 24. Pediatr Blood Cancer. 2014. PMID: 24664981 Free PMC article.
Initial testing (stage 1) of BAL101553, a novel tubulin binding agent, by the pediatric preclinical testing program.
Kolb EA, Gorlick R, Keir ST, Maris JM, Kang MH, Reynolds CP, Lock RB, Carol H, Wu J, Kurmasheva RT, Houghton PJ, Smith MA. Kolb EA, et al. Pediatr Blood Cancer. 2015 Jun;62(6):1106-9. doi: 10.1002/pbc.25329. Epub 2014 Nov 18. Pediatr Blood Cancer. 2015. PMID: 25407467 Free PMC article.
Assessing cytotoxic treatment effects in preclinical tumor xenograft models.
Wu J, Houghton PJ. Wu J, et al. J Biopharm Stat. 2009 Sep;19(5):755-62. doi: 10.1080/10543400903105158. J Biopharm Stat. 2009. PMID: 20183441 Free PMC article.
84 results
Jump to page
Feedback